Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study

AIMS: Severe acute respiratory syndrome coronavirus type 2 (SARS-COV-2) infection may increase the risk of developing dangerous symptoms among the elderly with underlying medical conditions. The aim of this study was to evaluate the safety and immunogenicity of the SARS-CoV-2 inactivated vaccine (Ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rongdong, Liu, Xiaoqin, Xie, Fangqin, Li, Junrong, Tang, Zhangbin, Wu, Yuying, Zhou, Peicong, Zhang, Dongjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702925/
https://www.ncbi.nlm.nih.gov/pubmed/36437418
http://dx.doi.org/10.1007/s13300-022-01343-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702925/
https://www.ncbi.nlm.nih.gov/pubmed/36437418
http://dx.doi.org/10.1007/s13300-022-01343-8

Ejemplares similares